Document Detail


Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas.
MedLine Citation:
PMID:  21496869     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Low-density lipoprotein receptor-related protein 1, a member of the low-density lipoprotein cholesterol receptor family, has been implicated in the progression of certain tumors; but it remains unclear whether it plays a role in infiltrating ductal breast carcinomas. We studied a series of 81 ductal breast tumors to determine the correlation of low-density lipoprotein receptor-related protein 1 overexpression with clinicopathologic and immunohistochemical characteristics associated with prognosis. Low-density lipoprotein receptor-related protein 1 overexpression was identified in 14% (11/81) of tumors and was correlated with a high nuclear grade (P = .043), high mitotic index (P = .006), and Ki-67 greater than 20% (P = .047). Furthermore, low-density lipoprotein receptor-related protein 1 expression was associated with aggressive carcinomas (triple-negative tumors [21%, 7/33] and Her-2/neu tumors [17%, 4/24]) but not with hormone-dependent carcinomas (0%, 0/24) (P = .040). There was no correlation between low-density lipoprotein receptor-related protein 1 expression and survival, but a trend was found between low-density lipoprotein receptor-related protein 1 overexpression and tumor recurrence. Low-density lipoprotein receptor-related protein 1 overexpression was related to proliferation and invasiveness in Her-2/neu and triple-negative breast carcinoma. Moreover, patients with low-density lipoprotein receptor-related protein 1-positive tumors had higher cholesterol levels (62.5%, 5/8) than those with low-density lipoprotein receptor-related protein 1-negative tumors (40%, 19/47). Nevertheless, the correlation between low-density lipoprotein receptor-related protein 1 and hypercholesterolemia was not statistically significant; but cholesterol levels were higher in patients with triple-negative breast carcinoma (60%, 15/25) and Her-2/neu carcinomas (40%, 6/15) than in luminal-A carcinomas (20%, 3/15) (P = .046). These findings suggest a relationship between hypercholesterolemia and aggressiveness of ductal breast carcinomas.
Authors:
Lluis Catasus; Alberto Gallardo; Vicenta Llorente-Cortes; Daniel Escuin; Josefina Muñoz; Ariadna Tibau; Gloria Peiro; Agusti Barnadas; Enrique Lerma
Related Documents :
23020239 - Anti-breast cancer agents from chinese herbal medicines.
16822879 - Epithelial displacement during breast needle core biopsy causes diagnostic difficulties...
6504769 - Accuracy of frozen section diagnosis in breast cancer detection. a review of 4436 biops...
12429309 - Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biops...
21119029 - Estrogen receptor-positive breast cancer in japanese women: trends in incidence, charac...
6781299 - Mammography of the postsurgical breast.
12546759 - Squamous cell carcinoma in solid-organ transplantation.
23349469 - Microinvasive lobular carcinoma arising in a fibroadenoma.
10921219 - Interobserver agreement of the nottingham histologic grading scheme for infiltrating du...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-13
Journal Detail:
Title:  Human pathology     Volume:  -     ISSN:  1532-8392     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421547     Medline TA:  Hum Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Pathology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica (IIB) Sant Pau, Autonomous University of Barcelona, 08041 Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatocyte nuclear factor-1? expression in clear cell adenocarcinomas of the bladder and urethra: di...
Next Document:  Human epidermal growth factor receptor 2, Na(+)/H(+) exchanger regulatory factor 1, and breast cance...